Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech -- Ignore unavailable to you. Want to Upgrade?

To: Larry G. who wrote (468)	3/26/1999 9:08:00 PM
From: checkmate	Respond to of 792

To all I have been watching this company for many years. I bought Mar18-22.97 $4.28 sold oct2297 to oct 29.97 average at $4.65...36,000 shares total. I have waited and waited for any reason other then a good concept to buy in again so far none. My feelings (ps I am in the pharmaceutical loop) ----- If something was to develop it would have by now If MBI has a product that would be a winner another RX co. would have joined forces by now Lots of promise--no delivery The world of drug resistant antibiotics is at the top of many of our worries, so much so that a candidate that would provide a new approach would be the princess at a ball of uglies. MBI has been investigated by many RX houses and NONE has bought in The price keeps drifting.. I read on this thread about support at $4.00 $3.00....$2.00 etc. The support is .01 cent. If mbi doesn't snag a major house soon the game is over. Gentlemen and Ladies--there are far better games and I believe an investment in MBI is money in the trash. I hate to say that because as I have said before the CONCEPT is DYNAMITE...the execution is flacid. Just my comments